Select the service you’re interested in, share a few details, and we’ll follow up to understand how we can support you.
Please provide the following details:
Feasibility
Conduct trial feasibility with access to a global network of 150,000+ investigators and sites—with different feasibility approaches depending on where you are in study planning.
| Early investigator engagement |
| Useful when you’re working in high-specialty or complex therapeutic areas where patient access is limited or eligibility criteria are restrictive. Engaging investigators early helps sense-check study design, comparators, and feasibility before plans are finalised. |
| Country-level feasibility |
| This is most relevant when you’re planning a multi-country study or narrowing down potential regions. This helps assess which countries are suitable based on patient availability, standard of care, regulatory pathways, timelines, and operational considerations. |
| Site-level feasibility |
| Comes into play once countries are shortlisted. This stage focuses on identifying the right investigators and sites, evaluating patient recruitment potential, site capability, and investigator interest to confirm whether the study can be realistically delivered. |
Phase II–IV Clinical Trials
Execution of phase II–IV, including selective FIH (first-in-human), from study start-up through to close-out, including site activation, monitoring, and ongoing coordination. A single point of contact coordinates activities across countries and functions, with the operational team working as an extension of your clinical development function. This approach is particularly useful for first-time sponsors or teams running lean clinical operations.
Medical Writing
You get end-to-end medical writing support, covering clinical trial and bioequivalence designs and protocols, CSRs, manuscripts, journal publications, scientific content, drug information reports, and SOPs. The team works closely with you to deliver clear, compliant documents on time, supporting smoother submissions and effective scientific communication.
IOR/EOR
If your study involves shipments into Japan, PMDA requirements can add complexity. We can act as your IOR/EOR to manage documentation review, identify regulatory gaps early, and ensure compliant customs clearance. Over the past six years, we’ve supported 80+ clinical trial imports into Japan, covering IMPs, ancillary supplies, non-IMPs, lab kits, medical devices, and diagnostic equipment.
If you need support in other countries apart from Japan, feel free to let us know and we’ll be happy to explore the requirements with you.
Clinical Data Management & Biostatistics
You get complete clinical data management support across the full study data lifecycle. This includes database design and setup, EDC configuration, data entry oversight, discrepancy and query management, interim data review, and database lock, following standard clinical data management workflows.
You get a biostatistics team with 15–25 years of experience, covering everything from sample size calculation and protocol-level statistical input to interim and final analysis and reporting outputs.
For Investigators & Research Sites
Connect with clinical trial opportunities globally as investigators or sites. Present your profiles in a clear, structured way with investigator experience, site infrastructure, therapeutic focus, and operational capabilities, all in one place. Ensure that relevant expertise and site capabilities are visible at the right stage of decision-making to CROs and sponsors.
If this is something you’d like to be part of, you’re welcome to register your early interest.